Bio Path Holdings Inc (BPTH)

[Snug9]

Barto, it's a sad commentary that you are excited to see BPTH hit $1. The analysts are saying the stock should be in the $2.5 to $5 range and a couple of years ago Zack's had it listed at $10. Now we get excited at $1? Management ineptitude.
Have your insider sources told you what "completing the enrollment of 19 patients by the end of the year..." means? Does this mean only that 19 patients are enrolled, 19 patients have been dosed, 19 patients have been dosed and the data has been analyzed and a study report has been filed witht the FDA?
I don't see an appreciable improvement to the stock price until approval has been given by the FDA which could be an additional 6 months if 19 patients have only been dosed by the end of the year; much longer if 19 patients have only been enrolled.
Puma Biotech stock jumped $75 per share when they were given approval of their breast cancer drug as essentially a last line of therapy treatment after everything else has been done. They have grade III diarrhea (can be deadly) as a side effect. Why should we be happy with $1, $2.5 or even $5 per share?